QL
AXSM icon

Quarry LP’s Axsome Therapeutics AXSM Stock Holding History

Quarry LP’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$845K Buy
5,000
+4,980
+24,900% +$860K 0.15% 109
2025
Q4 		$3.65K Sell
20
-1,230
-98% -$172K ﹤0.01% 1783
2025
Q3 		$152K Sell
1,250
-1,250
-50% -$141K 0.03% 427
2025
Q2 		$261K Buy
2,500
+1,100
+79% +$116K 0.06% 304
2025
Q1 		$163K Buy
1,400
+650
+87% +$74.1K 0.04% 346
2024
Q4 		$63.5K Sell
750
-1,250
-63% -$115K 0.01% 635
2024
Q3 		$180K Sell
2,000
-1,200
-38% -$105K 0.05% 263
2024
Q2 		$258K Buy
3,200
+1,400
+78% +$104K 0.07% 129
2024
Q1 		$144K Buy
+1,800
New +$151K 0.03% 201
2023
Q4 		– Sell
-1,745
Closed -$122K – 1391
2023
Q3 		$122K Buy
+1,745
New +$130K 0.03% 182

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quarry LP's AXSM Position: Q1 2026 in Review

Quarry LP increased its Axsome Therapeutics (AXSM) stake by 24,900% in Q1 2026, buying an estimated $860K and bringing the position to 5,000 shares worth $845K. The position accounts for 0.15% of the portfolio, ranked #109.

Quarry LP first reported a position in AXSM in Q3 2023 and has held it in 10 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Quarry LP held 5,000 shares of Axsome Therapeutics worth $845K as of Q1 2026.
  • Quarry LP bought 4,980 Axsome Therapeutics shares in Q1 2026, an estimated $860K.
  • Axsome Therapeutics made up 0.15% of Quarry LP's portfolio in Q1 2026, its #109 holding.
  • Quarry LP first reported a position in Axsome Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.